Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM29K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,851
Award facts
- Contract value 100% obligated
- $14,850.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,850.68 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract awarded on December 18, 2025, with an ultimate completion date of December 19, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated capability to meet federal requirements through open competition, with an extensive portfolio of delivery orders involving firm fixed pricing across multiple therapeutic domains. This award represents one of numerous delivery orders under the company's prime IDC with DLA, which also serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems as part of the DLA's Pharmaceutical Prime Vendor Global Program strategy.
Quick answers
Who was awarded contract SPE2DR26FM29K?
SPE2DR26FM29K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FM29K worth?
The government has obligated $14,851 on SPE2DR26FM29K.
Is contract SPE2DR26FM29K an order under another contract?
Yes. SPE2DR26FM29K is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM29K competed?
The extent of competition for SPE2DR26FM29K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award